Table 4: Univariate survival analysis of PFS and OS in 70 patients with endometrial carcinoma.

VariableNumberEstimated 5-year
PFS (%)
-valueEstimated 5-year
OS (%)

Age (years)0.1980.881
FIGO stage<0.0010.016
 I + II3994.789.7
 III + IV3156.166.7
 G2 + G34065.369.2
Lymph node metastasis0.0110.010
Depth of myometrial invasion0.0050.051
LVS involvement<0.001<0.001
Peritoneal cytology<0.001<0.001

FIGO: International Federation of Gynecology and Obstertics; LVS: lymph vascular space; PFS: progression-free survival; OS: overall survival and *log-rank test.